BackCentral Dogma, Gene Expression, Mutations, and CRISPR-Cas9: Study Guide for Genetics
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Central Dogma of Molecular Biology
Overview of Genetic Information Flow
The central dogma : Process of DNA transcription to RNA and translation to protein
DNA: Contains the genetic blueprint for all cellular functions.
Transcription: The process of synthesizing RNA from a DNA template.
Translation: The process of synthesizing a protein from an mRNA template.
Example: In human cells, the gene for hemoglobin is transcribed into mRNA, which is then translated into the hemoglobin protein.
Genes and Their Structure
Anatomy of a Structural Gene
A gene is is a unit of DNA that encodes (Transcribe/convert) to protein or RNA. or A gene is an organized unit of DNA sequences
Promoter: A DNA sequence upstream of the transcribed region that signals the start of transcription and serves as the binding site for RNA polymerase. It controls gene expression.
Regulatory sequence: DNA sequences that control when and how much of a gene's product is made. Or controls gene expression (on or Off)
Transcribed region: The segment of DNA that is copied into RNA during transcription.
Terminator: A DNA sequence that signals the end of transcription.
Example: The lac operon in Escherichia coli contains a promoter, operator (regulatory sequence), structural genes, and a terminator.
Transcription
Definition and Process
Transcription DNA sequence of a gene is copied into messenger RNA (mRNA). It occurs in three main stages: initiation, elongation, and termination.
Initiation: RNA polymerase binds to the promoter region (with sigma factor in prokaryotes), and the DNA double helix unwinds.
Elongation: RNA polymerase reads the template strand (3' to 5') and synthesizes a complementary RNA molecule (5' to 3'). Uracil (U) replaces thymine (T) in RNA.
Termination: RNA polymerase reaches a terminator sequence; transcription stops, and the RNA molecule is released. (pre-mRNA in eukaryotes) is released.
Location:
Prokaryotes: Transcription occurs in the cytoplasm.
Eukaryotes: Transcription occurs in the nucleus.
Example: In eukaryotic cells, the gene for insulin is transcribed in the nucleus.
RNA Processing in Eukaryotes
Making a Mature mRNA Transcript
Before mRNA can be translated, the pre-mRNA transcript undergoes processing in the nucleus. This includes capping, splicing, and tailing.
Capping: Addition of a 7-methylguanosine cap to the 5' end; protects mRNA and aids in ribosome binding.
Splicing: Removal of introns (non-coding sequences) and joining of exons (coding sequences) by the spliceosome.
Tailing: Addition of a poly-A tail (100-300 adenine nucleotides) to the 3' end; increases mRNA stability.
Example: The human beta-globin gene undergoes splicing to remove introns before translation.
Pre-mRNA vs. Mature mRNA
Feature | Pre-mRNA | Mature mRNA |
|---|---|---|
Overall Length | Longer | Shorter |
5' end | No cap | 7-methylguanosine cap |
3' end | No tail | Poly-A tail |
Interior sequences | Contains introns and exons | Contains only exons |
Cellular localization | Nucleus | Cytosol |
Translation
Definition and Process
Translation is the process by which genetic information encoded in mRNA is used to synthesize a polypeptide chain (protein). It occurs in the cytosol of eukaryotes and cytoplasm of prokaryotes.
Initiation: Small ribosomal subunit binds to mRNA; initiator tRNA binds to start codon (AUG); large subunit joins.
Elongation: Charged tRNA enters A site; peptide bond forms; ribosome translocates; tRNAs move through A, P, and E sites.
Termination: Ribosome encounters stop codon (UAA, UAG, UGA); release factor binds; polypeptide is released.
Example: Translation of mRNA encoding the enzyme hexokinase produces the functional protein.
Codon Structure of mRNA
Genetic code is read in triplets (codons).
64 possible codons: 61 specify amino acids, 3 are stop codons.
Start codon: AUG (methionine).
Code is degenerate and nearly universal.
Structure and Function of tRNA
Amino acid attachment site: 3' end of tRNA binds specific amino acid.
Anticodon loop: Three-nucleotide sequence complementary to mRNA codon.
Shape and secondary structure: Cloverleaf structure stabilized by hydrogen bonds.
Structure and Function of the Ribosome
Composed of rRNA and proteins.
Small and large subunits assemble on mRNA.
Three sites: A (aminoacyl), P (peptidyl), E (exit).
Catalyzes peptide bond formation.
Mutations
Classification and Consequences
Mutations are changes in the DNA sequence that can affect gene expression and protein function.
Base Substitution: Single nucleotide replaced.
Silent mutation: No change in amino acid sequence.
Missense mutation: Different amino acid incorporated.
Nonsense mutation: Premature stop codon; truncated protein.
Deletion/Insertion (Indels): Nucleotides removed or added.
Frameshift mutation: Alters reading frame; severe effect.
In-frame deletion/insertion: Adds/removes amino acids without changing frame.
Consequences:
Severe mutations: Nonsense, frameshift, large indels, or mutations affecting active sites often lead to loss of function (null mutation) or gain of function.
Less severe mutations: Missense mutations may have variable effects; silent mutations typically have no effect.
Example: Mutations in the BRCA1 gene can cause familial breast cancer by disrupting DNA repair protein function.
RNA Processing and Human Disease
Splicing Errors and Disease
Errors in RNA processing, especially splicing, can lead to human diseases. Splice variants may result from mutations at splice sites or within introns/exons.
Exon skipping: Exon omitted from mature mRNA.
Cryptic splicing: Incorrect splice site used; inclusion of intronic sequences or deletion of exonic portions.
Diagnostic Data: PCR and gel electrophoresis can detect abnormal mRNA transcripts, indicating splicing abnormalities.
Example: Thalassemia is diagnosed by identifying abnormal splice variants using gel electrophoresis.
CRISPR-Cas9 Gene Editing
Components and Mechanism
CRISPR-Cas9 is a gene-editing technology enabling precise DNA modifications.
Cas9: Endonuclease enzyme that cuts DNA.
Guide RNA (gRNA): Directs Cas9 to target DNA sequence; consists of crRNA (complementary to target) and tracrRNA (stabilizes gRNA).
PAM sequence: Short DNA motif (e.g., NGG) required for Cas9 binding.
Mechanism:
gRNA directs Cas9 to target DNA.
Cas9 binds and cuts DNA at target site (PAM required).
Cell's repair mechanisms activated:
Non-homologous end joining (NHEJ): Introduces indels; gene knockout.
Homology-directed repair (HDR): Uses template for precise editing; gene knock-in or correction.
Example: CRISPR-Cas9 can correct sickle cell disease mutations in hematopoietic stem cells.
Practice Problems and Applications
Example: Calculating Polypeptide Sequence from DNA
Given DNA coding strand: 5'-ATG GCT TTA CGA TAA-3'
mRNA sequence: 5'-AUG GCU UUA CGA UAA-3'
Translation:
AUG: Methionine (Met) - Start codon
GCU: Alanine (Ala)
UUA: Leucine (Leu)
CGA: Arginine (Arg)
UAA: Stop codon
Amino acid sequence: Met-Ala-Leu-Arg-Stop
Mutation Classification Table
Mutation Type | DNA Change | Protein Effect | Severity |
|---|---|---|---|
Silent | Base substitution | No change | Least severe |
Missense | Base substitution | Different amino acid | Variable |
Nonsense | Base substitution | Premature stop | Severe |
Frameshift | Indel (not multiple of 3) | Altered sequence, premature stop | Most severe |
In-frame indel | Indel (multiple of 3) | Add/remove amino acids | Variable |
Key Equations and Concepts
Transcription direction:
Template strand:
Translation:
Cellular Localization Comparison Table
Process | Prokaryotes | Eukaryotes |
|---|---|---|
Transcription | Cytoplasm | Nucleus |
Translation | Cytoplasm (coupled with transcription) | Cytosol |
RNA Processing | Minimal | Nucleus (capping, splicing, tailing) |
Application to Medical Case Studies
Predict transcription and translation products from DNA sequence.
Classify mutations and discuss their impact on protein structure/function.
Relate gene mutations to disease phenotypes (e.g., BRCA1 mutations in breast cancer).
Apply CRISPR-Cas9 to correct disease-causing mutations.
Additional info: Academic context was added to clarify the structure and function of genes, the central dogma, RNA processing, translation, mutation classification, and CRISPR-Cas9 mechanisms. Tables were inferred and expanded for clarity. Practice problems and key equations were included for exam preparation.